Prab: CSV import

2025-02-13T03:38:04Z

CSV import

← Older revision		Revision as of 03:38, 13 February 2025
Line 1:		Line 1:
	~~'''~~TCS-OX2-29''' is a [[pharmacological]] tool used in scientific research. It is a selective [[antagonist]] for the [[orexin receptor]] OX2, which is involved in the regulation of [[sleep-wake cycle]], [[appetite]], and [[mood]]. TCS-OX2-29 is used to study the role of the orexin system in various physiological and pathological processes.		== TCS-OX2-29 ==

	~~== History ==~~		[[File:TCS-OX2-29.svg\|thumb\|right\|Chemical structure of TCS-OX2-29]]

	TCS-OX2-29 ~~was first synthesized and characterized by scientists at~~ the [[~~Takeda Pharmaceutical Company~~]] in ~~Japan~~. ~~It was developed as part~~ of a ~~research program aimed at discovering new treatments for~~ [[~~insomnia~~]] and ~~other sleep disorders~~.		'''TCS-OX2-29''' is a selective antagonist of the [[orexin receptor]] OX2, which is involved in the regulation of [[wakefulness]] and [[sleep]]. Orexin receptors are a type of [[G protein-coupled receptor]] that bind the [[neuropeptide]]s [[orexin A]] and [[orexin B]]. These receptors play a crucial role in maintaining [[arousal]], [[appetite]], and [[energy homeostasis]].

	== ~~Pharmacology~~ ==		== Mechanism of Action ==

	TCS-OX2-29 ~~is a potent and selective antagonist for~~ the OX2 receptor~~. It binds to the receptor and prevents it from being activated by the [[neuropeptide]] orexin~~, thereby ~~inhibiting~~ the ~~effects~~ of orexin ~~in the body~~. This can lead to ~~increased sleepiness~~ and ~~decreased appetite~~, ~~among other effects~~.		TCS-OX2-29 functions by selectively inhibiting the OX2 receptor, thereby blocking the action of orexin peptides at this receptor site. This inhibition can lead to a decrease in [[arousal]] and an increase in [[sleep]], making it a potential therapeutic agent for conditions such as [[insomnia]] and [[narcolepsy]].

	== ~~Uses~~ ==		== Pharmacological Effects ==

	TCS-OX2-29 is ~~primarily used in scientific research to study~~ the ~~role~~ of the ~~orexin system in various physiological~~ and ~~pathological processes~~. ~~For example, it has been used to investigate~~ the role of orexin in ~~the regulation of~~ sleep~~-wake cycle, appetite,~~ and ~~mood. It has also been used to study the potential therapeutic effects of OX2 receptor antagonists~~ in conditions ~~such as insomnia, [[narcolepsy]], and [[obesity]]~~.		The primary effect of TCS-OX2-29 is the modulation of sleep-wake cycles. By antagonizing the OX2 receptor, TCS-OX2-29 can promote sleep and reduce wakefulness. This effect is particularly useful in studying the role of orexin in sleep disorders and in developing treatments for such conditions.

	== ~~Safety~~ ==		== Research and Development ==

	~~As a research tool,~~ TCS-OX2-29 ~~is not intended for human consumption~~. ~~Its safety~~ and ~~potential side effects have not been thoroughly studied~~ in ~~humans~~.		Research on TCS-OX2-29 has focused on its potential applications in treating sleep disorders. Studies have shown that blocking the OX2 receptor can lead to increased sleep duration and improved sleep quality. This makes TCS-OX2-29 a valuable tool in both basic research and clinical applications.

	== ~~See also~~ ==		== Related Pages ==

	* [[Orexin receptor]]		* [[Orexin receptor]]
	* [[Orexin]]		* [[Orexin A]]
	* [[~~Takeda Pharmaceutical Company~~]]		* [[Orexin B]]
			* [[Insomnia]]
			* [[Narcolepsy]]
			* [[G protein-coupled receptor]]

	[[Category:Pharmacology]]		[[Category:Pharmacology]]
	~~[[Category:Research tools]]~~
	[[Category:Neuroscience]]		[[Category:Neuroscience]]
	~~{{pharma-stub}}~~
	~~{{neuroscience-stub}}~~

Prab: CSV import

2024-02-29T19:35:07Z

CSV import

New page

'''TCS-OX2-29''' is a [[pharmacological]] tool used in scientific research. It is a selective [[antagonist]] for the [[orexin receptor]] OX2, which is involved in the regulation of [[sleep-wake cycle]], [[appetite]], and [[mood]]. TCS-OX2-29 is used to study the role of the orexin system in various physiological and pathological processes.

== History ==

TCS-OX2-29 was first synthesized and characterized by scientists at the [[Takeda Pharmaceutical Company]] in Japan. It was developed as part of a research program aimed at discovering new treatments for [[insomnia]] and other sleep disorders.

== Pharmacology ==

TCS-OX2-29 is a potent and selective antagonist for the OX2 receptor. It binds to the receptor and prevents it from being activated by the [[neuropeptide]] orexin, thereby inhibiting the effects of orexin in the body. This can lead to increased sleepiness and decreased appetite, among other effects.

== Uses ==

TCS-OX2-29 is primarily used in scientific research to study the role of the orexin system in various physiological and pathological processes. For example, it has been used to investigate the role of orexin in the regulation of sleep-wake cycle, appetite, and mood. It has also been used to study the potential therapeutic effects of OX2 receptor antagonists in conditions such as insomnia, [[narcolepsy]], and [[obesity]].

== Safety ==

As a research tool, TCS-OX2-29 is not intended for human consumption. Its safety and potential side effects have not been thoroughly studied in humans.

== See also ==

* [[Orexin receptor]]
* [[Orexin]]
* [[Takeda Pharmaceutical Company]]

[[Category:Pharmacology]]
[[Category:Research tools]]
[[Category:Neuroscience]]
{{pharma-stub}}
{{neuroscience-stub}}

TCS-OX2-29 - Revision history

Prab: CSV import

Prab: CSV import